Epsilon End Period Cash Flow vs Net Income Analysis

EPN Stock

0.02 0.00 0.00%

Epsilon Healthcare financial indicator trend analysis is much more than just examining Epsilon Healthcare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Epsilon Healthcare is a good investment. Please check the relationship between Epsilon Healthcare End Period Cash Flow and its Net Income accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epsilon Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

End Period Cash Flow vs Net Income

End Period Cash Flow vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Epsilon Healthcare End Period Cash Flow account and Net Income. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Epsilon Healthcare's End Period Cash Flow and Net Income is -0.16. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Net Income in the same time period over historical financial statements of Epsilon Healthcare, assuming nothing else is changed. The correlation between historical values of Epsilon Healthcare's End Period Cash Flow and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Epsilon Healthcare are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of End Period Cash Flow i.e., Epsilon Healthcare's End Period Cash Flow and Net Income go up and down completely randomly.

Correlation Coefficient

-0.16

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Epsilon Healthcare financial statement analysis. It represents the amount of money remaining after all of Epsilon Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from Epsilon Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Epsilon Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epsilon Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Epsilon Healthcare's Tax Provision is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 4.7 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.7 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	799.4K	577.5K	664.2K	347.9K
Depreciation And Amortization	1.6M	1.9M	2.1M	2.2M

Interest Expense Depreciation And Amortization

Epsilon Healthcare fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Total Liab	Total Current Assets	Cash And Equivalents	Intangible Assets	Common Stock	Net Tangible Assets	Non Currrent Assets Other	Other Assets	Good Will	Other Current Assets	Other Stockholder Equity	Net Invested Capital
Total Assets		0.4	0.61	0.79	0.9	0.26	-0.62	0.51	0.16	0.97	0.16	0.55	0.59	0.68	0.76	0.63	0.61	-0.88	0.78	0.45	-0.27	-0.52	-0.41	0.48	-0.87	0.3
Other Current Liab	0.4		0.87	-0.17	0.58	0.72	-0.88	0.96	-0.52	0.45	-0.52	0.94	0.96	-0.23	0.72	-0.08	0.33	-0.7	0.75	-0.49	-0.07	-0.77	-0.92	-0.24	-0.68	-0.68
Total Current Liabilities	0.61	0.87		0.02	0.72	0.81	-0.97	0.97	-0.46	0.65	-0.46	0.95	0.93	0.22	0.9	0.11	0.3	-0.8	0.89	-0.38	0.05	-0.87	-0.73	0.06	-0.8	-0.41
Total Stockholder Equity	0.79	-0.17	0.02		0.53	-0.32	-0.03	-0.09	0.61	0.69	0.61	-0.03	0.01	0.71	0.24	0.79	0.59	-0.5	0.27	0.84	-0.3	0.02	0.1	0.54	-0.44	0.73
Property Plant And Equipment Net	0.9	0.58	0.72	0.53		0.55	-0.8	0.66	-0.21	0.97	-0.21	0.67	0.74	0.51	0.9	0.27	0.38	-0.88	0.89	0.25	-0.39	-0.68	-0.65	0.45	-0.98	0.0
Net Debt	0.26	0.72	0.81	-0.32	0.55		-0.83	0.8	-0.87	0.43	-0.87	0.74	0.76	0.03	0.71	-0.45	-0.24	-0.43	0.63	-0.45	-0.05	-0.79	-0.68	0.1	-0.65	-0.49
Retained Earnings	-0.62	-0.88	-0.97	-0.03	-0.8	-0.83		-0.96	0.52	-0.69	0.52	-0.95	-0.96	-0.18	-0.93	-0.03	-0.29	0.84	-0.93	0.35	0.09	0.88	0.83	-0.11	0.87	0.47
Accounts Payable	0.51	0.96	0.97	-0.09	0.66	0.8	-0.96		-0.52	0.56	-0.52	0.99	0.98	-0.01	0.83	0.0	0.33	-0.78	0.85	-0.47	0.03	-0.82	-0.86	-0.11	-0.76	-0.58
Cash	0.16	-0.52	-0.46	0.61	-0.21	-0.87	0.52	-0.52		-0.05	1.0	-0.45	-0.5	0.33	-0.32	0.81	0.52	0.02	-0.24	0.52	0.07	0.49	0.57	0.07	0.31	0.6
Non Current Assets Total	0.97	0.45	0.65	0.69	0.97	0.43	-0.69	0.56	-0.05		-0.05	0.57	0.63	0.64	0.83	0.42	0.43	-0.85	0.81	0.42	-0.34	-0.58	-0.5	0.51	-0.94	0.22
Cash And Short Term Investments	0.16	-0.52	-0.46	0.61	-0.21	-0.87	0.52	-0.52	1.0	-0.05		-0.45	-0.5	0.33	-0.32	0.81	0.52	0.02	-0.24	0.52	0.07	0.49	0.57	0.07	0.31	0.6
Net Receivables	0.55	0.94	0.95	-0.03	0.67	0.74	-0.95	0.99	-0.45	0.57	-0.45		0.99	0.02	0.82	0.08	0.44	-0.83	0.86	-0.45	0.06	-0.78	-0.86	-0.1	-0.77	-0.56
Common Stock Shares Outstanding	0.59	0.96	0.93	0.01	0.74	0.76	-0.96	0.98	-0.5	0.63	-0.5	0.99		0.01	0.84	0.03	0.41	-0.83	0.87	-0.36	-0.07	-0.8	-0.92	-0.05	-0.83	-0.55
Inventory	0.68	-0.23	0.22	0.71	0.51	0.03	-0.18	-0.01	0.33	0.64	0.33	0.02	0.01		0.44	0.6	0.22	-0.41	0.4	0.49	-0.17	-0.27	0.26	0.83	-0.43	0.64
Total Liab	0.76	0.72	0.9	0.24	0.9	0.71	-0.93	0.83	-0.32	0.83	-0.32	0.82	0.84	0.44		0.2	0.3	-0.87	0.98	-0.13	-0.14	-0.83	-0.66	0.3	-0.92	-0.24
Total Current Assets	0.63	-0.08	0.11	0.79	0.27	-0.45	-0.03	0.0	0.81	0.42	0.81	0.08	0.03	0.6	0.2		0.8	-0.51	0.29	0.43	0.01	-0.02	0.18	0.27	-0.21	0.49
Cash And Equivalents	0.61	0.33	0.3	0.59	0.38	-0.24	-0.29	0.33	0.52	0.43	0.52	0.44	0.41	0.22	0.3	0.8		-0.71	0.46	0.16	-0.05	-0.15	-0.33	0.03	-0.39	0.02
Intangible Assets	-0.88	-0.7	-0.8	-0.5	-0.88	-0.43	0.84	-0.78	0.02	-0.85	0.02	-0.83	-0.83	-0.41	-0.87	-0.51	-0.71		-0.93	-0.03	0.17	0.67	0.69	-0.24	0.9	0.15
Common Stock	0.78	0.75	0.89	0.27	0.89	0.63	-0.93	0.85	-0.24	0.81	-0.24	0.86	0.87	0.4	0.98	0.29	0.46	-0.93		-0.16	-0.16	-0.81	-0.71	0.27	-0.91	-0.3
Net Tangible Assets	0.45	-0.49	-0.38	0.84	0.25	-0.45	0.35	-0.47	0.52	0.42	0.52	-0.45	-0.36	0.49	-0.13	0.43	0.16	-0.03	-0.16		-0.32	0.37	0.34	0.43	-0.13	0.87
Non Currrent Assets Other	-0.27	-0.07	0.05	-0.3	-0.39	-0.05	0.09	0.03	0.07	-0.34	0.07	0.06	-0.07	-0.17	-0.14	0.01	-0.05	0.17	-0.16	-0.32		0.36	0.24	-0.61	0.32	-0.04
Other Assets	-0.52	-0.77	-0.87	0.02	-0.68	-0.79	0.88	-0.82	0.49	-0.58	0.49	-0.78	-0.8	-0.27	-0.83	-0.02	-0.15	0.67	-0.81	0.37	0.36		0.65	-0.35	0.73	0.42
Good Will	-0.41	-0.92	-0.73	0.1	-0.65	-0.68	0.83	-0.86	0.57	-0.5	0.57	-0.86	-0.92	0.26	-0.66	0.18	-0.33	0.69	-0.71	0.34	0.24	0.65		0.16	0.74	0.67
Other Current Assets	0.48	-0.24	0.06	0.54	0.45	0.1	-0.11	-0.11	0.07	0.51	0.07	-0.1	-0.05	0.83	0.3	0.27	0.03	-0.24	0.27	0.43	-0.61	-0.35	0.16		-0.38	0.46
Other Stockholder Equity	-0.87	-0.68	-0.8	-0.44	-0.98	-0.65	0.87	-0.76	0.31	-0.94	0.31	-0.77	-0.83	-0.43	-0.92	-0.21	-0.39	0.9	-0.91	-0.13	0.32	0.73	0.74	-0.38		0.11
Net Invested Capital	0.3	-0.68	-0.41	0.73	0.0	-0.49	0.47	-0.58	0.6	0.22	0.6	-0.56	-0.55	0.64	-0.24	0.49	0.02	0.15	-0.3	0.87	-0.04	0.42	0.67	0.46	0.11

Click cells to compare fundamentals

Epsilon Healthcare Account Relationship Matchups

Epsilon Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	27.8M	37.3M	30.6M	20.5M	23.6M	28.6M
Other Current Liab	308.5K	390.6K	158.4K	1.0M	1.2M	1.3M
Total Current Liabilities	894.4K	7.1M	7.1M	7.9M	9.1M	9.6M
Total Stockholder Equity	22.3M	25.3M	19.6M	9.3M	8.3M	15.7M
Property Plant And Equipment Net	19.0M	20.1M	17.6M	15.6M	18.0M	14.3M
Net Debt	(2.8M)	(1.9M)	2.0M	2.3M	2.7M	2.8M
Retained Earnings	(17.2M)	(29.0M)	(36.0M)	(49.6M)	(44.6M)	(42.4M)
Accounts Payable	585.8K	2.3M	2.4M	4.3M	5.0M	5.2M
Cash	3.6M	7.0M	2.3M	862.0K	775.8K	737.0K
Non Current Assets Total	21.7M	26.3M	22.7M	15.7M	18.1M	19.8M
Cash And Short Term Investments	3.6M	7.0M	2.3M	862.0K	775.8K	737.0K
Net Receivables	583.5K	1.5M	2.2M	3.1M	3.6M	3.8M
Common Stock Shares Outstanding	133.0M	158.9M	193.0M	300.4M	345.4M	362.7M
Long Term Debt Total	711.3K	1.3M	660.0K	649.3K	746.7K	588.7K
Liabilities And Stockholders Equity	27.8M	37.3M	30.6M	20.5M	23.6M	28.6M
Inventory	1.3M	2.1M	2.4M	611.1K	702.8K	667.6K
Total Liab	5.5M	11.9M	11.0M	11.2M	12.9M	7.1M
Total Current Assets	6.1M	11.0M	7.8M	4.8M	4.3M	6.4M
Accumulated Other Comprehensive Income	11.1M	11.6M	11.5M	12.0M	13.8M	10.9M
Intangible Assets	1.6M	1.1M	2.4M	475.5K	504.7K	0.0
Common Stock	28.4M	42.8M	44.8M	46.9M	53.9M	34.2M
Net Tangible Assets	19.6M	19.2M	14.4M	9.9M	8.9M	13.5M
Non Currrent Assets Other	(21.4M)	6.5K	126.9K	116.5K	133.9K	140.6K
Other Assets	248.1K	264.5K	126.9K	116.5K	104.8K	99.6K
Non Current Liabilities Total	4.6M	4.9M	3.8M	3.3M	3.8M	3.8M
Other Current Assets	647.7K	412.4K	705.0K	145.8K	167.7K	159.3K
Other Stockholder Equity	(24.3K)	(191.0K)	(749.0K)	(611.1K)	(550.0K)	(522.5K)
Net Invested Capital	22.3M	29.3M	24.0M	11.8M	10.6M	18.3M
Net Working Capital	5.2M	4.5M	1.0M	(3.2M)	(2.9M)	(2.7M)
Property Plant Equipment	18.8M	19.9M	17.5M	15.6M	18.0M	16.5M
Short Long Term Debt Total	711.3K	5.1M	4.3M	3.2M	3.7M	3.0M
Capital Lease Obligations	711.3K	1.3M	775.2K	649.3K	746.7K	849.5K
Capital Stock	28.4M	41.8M	44.8M	46.9M	53.9M	40.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Epsilon Stock Analysis

When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC